Cover Image
市場調查報告書

全球研究用抗體、試劑市場:機會分析與產業預測

Research Antibodies And Reagents Market - Global Opportunity Analysis And Industry Forecast (2018-2023)

出版商 Meticulous Market Research Pvt. Ltd. 商品編碼 607591
出版日期 內容資訊 英文 321 Pages
訂單完成後即時交付
價格
Back to Top
全球研究用抗體、試劑市場:機會分析與產業預測 Research Antibodies And Reagents Market - Global Opportunity Analysis And Industry Forecast (2018-2023)
出版日期: 2018年01月31日 內容資訊: 英文 321 Pages
簡介

本報告提供全球研究用抗體、試劑的市場調查分析,市場概要,各市場區隔的市場分析,各地區分析,競爭情形,企業簡介等系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場考察

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題
  • 市場佔有率分析:各主要企業

第5章 研究用抗體、試劑市場:各產品

  • 簡介
  • 試劑
  • 抗體

第6章 研究用抗體、試劑市場:各技術

  • 簡介
  • 免疫印漬術 (WB)
  • 免疫螢光法 (IF)
  • 免疫吸著法
  • 流式細胞技術
  • 免疫組織化學法
  • 免疫沉澱分析法
  • 其他

第7章 研究用抗體、試劑市場:各用途

  • 簡介
  • 蛋白質體學
  • 藥物研發與開發
  • 基因學

第8章 研究用抗體、試劑市場:各終端用戶

  • 簡介
  • 製藥、生物產業
  • 學術、研究機關
  • CRO

第9章 研究用抗體、試劑市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第10章 競爭情形

  • 簡介
  • 核准
  • 夥伴關係,契約,聯盟
  • M&A
  • 新產品銷售
  • 事業擴大

第11章 企業簡介

  • GE Healthcare
  • Merck & Co., Inc.
  • Thermo Fisher Scientific, Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd
  • Rockland Immunochemicals Inc.
  • Sanofi
  • Johnson & Johnson (J&J)
  • Eli Lilly and Company
  • Teva Pharmaceuticals Industries Limited
  • Abcam plc
  • Agilent Technologies, Inc.
  • Becton Dickinson
  • Danaher Corporation
  • Lonza
  • PerkinElmer, Inc.
  • GenScript Biotech Corporation
  • Bio-Techne Corporation
  • Bio-Rad Laboratories, Inc.
  • Santa Cruz Biotechnology, Inc.
  • BioLegend, Inc.
  • Cell Signaling Technology, Inc.

第12章 附錄

目錄
Product Code: MRBT-10427

Research Antibodies and Reagents Market by Product (Reagents And Research Antibodies), By Technology (Western Blotting, Immunofluorescence, Immunosorbent Assays, Flow Cytometry, Immunohistochemistry, and Immunoprecipitation), by Application (Proteomics, Drug Discovery & Development, and Genomics), and by End User (Pharmaceutical & Biotechnology Industry, Academic & Research Institutes, and Contract Research Organizations)- Global Opportunity Analysis and Industry Forecast to 2023

Global research antibodies and reagents market is expected to reach USD 13,276.5 million by 2023, at a CAGR of 6.5% during the forecast period of 2018 to 2023.

Succeeding an extensive secondary and primary research on research antibodies & reagents and in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, opportunities, and challenges in the market. Growing proteomics and genomics research studies, increasing funding for various research activities, and growing industry-academia collaborations are the key factors expected to propel the industry growth during the forecast period.

Traditionally, researchers were using conventional technologies such as Sanger's to sequence and analyze single gene, amplicon targets, genomic fragments, and short tandem repeats. However, it proved to be time consuming, less accurate, and low throughput technique for proteomics and genomics research. To overcome these drawbacks, researchers developed antibody based technologies for high throughput, accuracy, and more specificity. The various government authorities are supporting this R&D growth by providing funding and reducing approval time for new drug molecules.

Also, increasing industry-academia collaboration expands the relevance of research carried out in public institutions, thereby increasing the commercialization of public R&D outcomes, and the mobility in both private & public sector. Moreover, rising demand for protein therapeutics and personalized medicines, growing investment and focus on stem cell research, need for new biomarker identification, and increasing contribution from emerging economies provide significant opportunities in the research antibodies and reagents market. However, factors such as high cost with more developmental time for potential antibodies is expected to hinder the growth of this market to some extent. In addition, the issues related to quality and stability of research antibodies and intense pricing pressure on leading market players poses a great challenge for the various stakeholders in this market.

The study offers a comprehensive analysis of research antibodies and reagents market with respect to various products, technologies, applications, and end users. The research antibodies and reagents market is segmented on the basis of product, (reagents and research antibodies), technology, (western blotting, immunofluroscence, immunosorbent assays, flow cytometry, immunohistochemistry, immunoprecipitation, and others), application (proteomics, drug discovery & development, and genomics), and end user (pharmaceutical & biotechnology industry, academic & research institutes, and contract research organizations). The reagents commanded the largest share in the global research antibodies and reagents market in 2017, mainly attributed to high demand for various reagents in many routine assays and techniques with increased spending on research & development.

Further, an in-depth analysis of the geographic scenario of the industry provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. The geographic analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, and government & private investments. The geographic analysis section also comments on the key market players, shaping the growth of the industry in the respective countries. Geographically, North America commanded the largest share in the global research antibodies and reagents market in 2017, mainly due to the well-established healthcare system in the region, higher acceptance of advanced technologies, raising non-communicable diseases, increasing drug discovery programs & related rise in pharmaceutical R&D, rising focus on proteomics and genomics research, availability of research funding, and presence of many key players in this market.

The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2014-2017). The key players in the global research antibodies and reagents market are GE Healthcare (U.S.), Merck & Co., Inc.(U.S.), Thermo Fisher Scientific Inc.(U.S.), Amgen Inc.(U.S.), Sanofi (France), F. Hoffmann La-Roche Ltd (Switzerland), Rockland Immunochemicals Inc.(U.S.), Johnson & Johnson (U.S.), Agilent Technologies, Inc.(U.S.), Eli Lilly and Company (U.S.), Becton Dickinsonand Company (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc.(U.S.), GenScript Biotech Corporation (U.S.), Lonza (Switzerland), Bio-Techne Corporation (U.S.), Bio-Rad Laboratories, Inc.(U.S.), Teva Pharmaceutical Industries Limited (Israel), Santa Cruz Biotechnology, Inc.(U.S.), BioLegend, Inc.(U.S.), Abcam PLC (U.K.), and Cell Signaling Technology, Inc.(U.S.).

Scope of the report

Market by Product:

  • Reagents
    • Media and Serum
    • Stains and Dyes
    • Probes
    • Buffers
    • Solvents
    • Enzymes
    • Proteins
    • Others
  • Research Antibodies
    • Research Antibodies Market, by Type
      • Primary Antibodies
      • Secondary Antibodies
    • Research Antibodies Market, by Production
      • Monoclonal Antibodies
      • Polyclonal Antibodies
      • Antibody Fragments
    • Research Antibodies Market, by Source
      • Mouse
      • Rabbit
      • Others
    • Research Antibodies Market, by Research Areas
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Immunology
      • Neurology
      • Stem Cell
      • Others

Market by Technology:

  • Western Blotting
  • Immunofluorescence
  • Immunosorbent Assays
  • Flow Cytometry
  • Immunohistochemistry
  • Immunoprecipitation
  • Others

Market by Application:

  • Proteomics
  • Drug Discovery & Development
  • Genomics

Market by End User:

  • Pharmaceutical and Biotechnology Industry
  • Academic and Research Institutes
  • Contract Research Organizations

Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Market Ecosystem
  • 1.2. Currency and Limitations
    • 1.2.1. Currency
    • 1.2.2. Limitations
  • 1.3. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Secondary Research
    • 2.1.2. Primary Research

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
      • 4.2.1.1. Rising Proteomics and Genomics Research Studies
      • 4.2.1.2. Increase in the Funding for Research Activities
      • 4.2.1.3. Growing Industry-Academia Collaboration
      • 4.2.1.4. Other Drivers
    • 4.2.2. Restraints
      • 4.2.2.1. High Cost and Time Related to Identification and Development of Potential Antibodies
      • 4.2.2.1. Other Restraints
    • 4.2.3. Opportunities
      • 4.2.3.1. Growing Demand for Protein Therapeutics and Personalized Medicines
      • 4.4.3.2. Rising Investment and Focus on Stem-Cell Research
      • 4.4.3.3. Rising Need for New Biomarker Identification
      • 4.2.3.4. Significant Opportunities from Emerging Asia-Pacific and Latin-American Markets
      • 4.4.3.5. Other Opportunities
    • 4.2.4. Challenges
      • 4.2.4.1. Issues Related to Quality and Stability of Research Antibodies
      • 4.2.4.2. Intense Pricing Pressure on Leading Players
      • 4.2.4.3. Other Challenges
  • 4.3. Market Share Analysis, by Key Players

5. Research Antibodies and Reagents Market, by Product

  • 5.1. Introduction
  • 5.2. Reagents
    • 5.2.1. Media and Serum
    • 5.2.2. Stains and Dyes
    • 5.2.3. Probes
    • 5.2.4. Buffers
    • 5.2.5. Solvents
    • 5.2.6. Enzymes
    • 5.2.7. Proteins
    • 5.2.8. Others
  • 5.3. Antibodies
    • 5.3.1. Antibodies Market, by Type
      • 5.3.1.1. Primary Antibodies
      • 5.3.1.2. Secondary Antibodies
    • 5.3.2. Antibodies Market, by Production
      • 5.3.2.1. Monoclonal Antibodies
      • 5.3.2.2. Polyclonal Antibodies
      • 5.3.2.3. Antibody Fragments
    • 5.3.3. Antibodies Market, by Source
      • 5.3.3.1. Mouse
      • 5.3.3.2. Rabbit
      • 5.3.3.3. Others
    • 5.3.4. Antibodies Market, by Research Area
      • 5.3.4.1. Oncology
      • 5.3.4.2. Infectious Diseases
      • 5.3.4.3. Cardiovascular Disease
      • 5.3.4.4. Immunology
      • 5.3.4.5. Neurology
      • 5.3.4.6. Stem Cell
      • 5.3.4.7. Others

6. Research Antibodies and Reagents Market, by Technology

  • 6.1. Introduction
  • 6.2. Western Blotting
  • 6.3. Immunofluorescence
  • 6.4. Immunosorbent Assays
  • 6.5. Flow Cytometry
  • 6.6. Immunohistochemistry
  • 6.7. Immunoprecipitation
  • 6.8. Others

7. Research Antibodies and Reagents Market, by Application

  • 7.1. Introduction
  • 7.2. Proteomics
  • 7.3. Drug Discovery and Development
  • 7.4. Genomics

8. Research Antibodies and Reagents Market, by End Users

  • 8.1. Introduction
  • 8.2. Pharmaceutical & Biotechnology Industry
  • 8.3. Academic & Research Institutes
  • 8.4. Contract Research Organizations

9. Research Antibodies and Reagents Market, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific
  • 9.5. Rest of the World
    • 9.5.1. Latin America
    • 9.5.2. Middle East & Africa

10. Competitive Landscape

  • 10.1 Introduction
  • 10.2. Approvals
  • 10.3. Partnerships, Agreements, & Collaborations
  • 10.4. Mergers & Acquisitions
  • 10.5. New Product Launches
  • 10.6. Expansions

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 11.1. GE Healthcare
  • 11.2. Merck & Co., Inc.
  • 11.3. Thermo Fisher Scientific, Inc.
  • 11.4. Amgen Inc.
  • 11.5. F. Hoffmann-La Roche Ltd
  • 11.6. Rockland Immunochemicals Inc.
  • 11.7. Sanofi
  • 11.8. Johnson & Johnson (J&J)
  • 11.9. Eli Lilly and Company
  • 11.10. Teva Pharmaceuticals Industries Limited
  • 11.11. Abcam plc
  • 11.12. Agilent Technologies, Inc.
  • 11.13. Becton Dickinson
  • 11.14. Danaher Corporation
  • 11.15. Lonza
  • 11.16. PerkinElmer, Inc.
  • 11.17. GenScript Biotech Corporation
  • 11.18. Bio-Techne Corporation
  • 11.19. Bio-Rad Laboratories, Inc.
  • 11.20. Santa Cruz Biotechnology, Inc.
  • 11.21. BioLegend, Inc.
  • 11.22. Cell Signaling Technology, Inc.

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Available Customization

List of Tables

  • Table 1 Global Research Antibodies and Reagents Market Drivers: Impact Analysis (2018-2023)
  • Table 2 Global Research Antibodies and Reagents Market Restraints: Impact Analysis (2018-2023)
  • Table 3 Global Research Antibodies and Reagents Market Size, by Product, 2016-2023 (USD Million)
  • Table 4 Global Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 5 Global Reagents Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 6 Global Media and Serum Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 7 Global Stains and Dyes Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 8 Global Probes Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 9 Global Buffers Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 10 Global Solvents Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 11 Global Enzymes Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 12 Global Proteins Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 13 Global Other Reagents Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 14 Global Research Antibodies Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 15 Global Research Antibodies Market Size, Type, 2016-2023 (USD Million)
  • Table 16 Global Primary Antibodies Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 17 Global Secondary Antibodies Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 18 Global Research Antibodies Market Size, Production Type, 2016-2023 (USD Million)
  • Table 19 Global Monoclonal Antibodies Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 20 Global Polyclonal Antibodies Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 21 Global Antibody Fragments Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 22 Global Research Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 23 Global Mouse Derived Antibodies Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 24 Global Rabbit Derived Antibodies Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 25 Global Other Sources Derived Antibodies Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 26 Global Research Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 27 Global Research Antibodies Market Size for Oncology, by Country/Region, 2016-2023 (USD Million)
  • Table 28 Global Research Antibodies Market Size for Infectious Diseases, by Country/Region, 2016-2023 (USD Million)
  • Table 29 Global Research Antibodies Market Size for Cardiovascular Diseases, by Country/Region, 2016-2023 (USD Million)
  • Table 30 Global Research Antibodies Market Size for Immunology, by Country/Region, 2016-2023 (USD Million)
  • Table 31 Global Research Antibodies Market Size for Neurology, by Country/Region, 2016-2023 (USD Million)
  • Table 32 Global Research Antibodies Market Size for Stem Cell, by Country/Region, 2016-2023 (USD Million)
  • Table 33 Global Research Antibodies Market Size for Other Research Area, by Country/Region, 2016-2023 (USD Million)
  • Table 34 Global Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 35 Global Research Antibodies and Reagents Market Size for Western Blotting, by Country/Region, 2016-2023 (USD Million)
  • Table 36 Global Research Antibodies and Reagents Market Size for Immunofluorescence, by Country/Region, 2016-2023 (USD Million)
  • Table 37 Global Research Antibodies and Reagents Market Size for Immunosorbent Assays, by Country/Region, 2016-2023 (USD Million)
  • Table 38 Global Research Antibodies and Reagents Market Size for Flow Cytometry, by Country/Region, 2016-2023 (USD Million)
  • Table 39 Global Research Antibodies and Reagents Market Size for Immunohistochemistry, by Country/Region, 2016-2023 (USD Million)
  • Table 40 Global Research Antibodies and Reagents Market Size for Immunoprecipitation, by Country/Region, 2016-2023 (USD Million)
  • Table 41 Global Research Antibodies and Reagents Market Size for Other Technologies, by Country/Region, 2016-2023 (USD Million)
  • Table 42 Global Research Antibodies and Reagents Market Size, by Application, 2016-2023 (USD Million)
  • Table 43 Global Research Antibodies and Reagents Market Size for Proteomics, by Country/Region, 2016-2023 (USD Million)
  • Table 44 Global Research Antibodies and Reagents Market Size for Drug Discovery and Development, by Country/Region, 2016-2023 (USD Million)
  • Table 45 Global Research Antibodies and Reagents Market Size for Genomics, by Country/Region, 2016-2023 (USD Million)
  • Table 46 Global Research Antibodies and Reagents Market Size, by End User, 2016-2023 (USD Million)
  • Table 47 Global Research Antibodies and Reagents Market Size for Pharmaceutical &Biotechnology Industry, by Country/Region, 2016-2023 (USD Million)
  • Table 48 Global Research Antibodies and Reagents Market Size for Academic & Research Institutes, by Country/Region, 2016-2023 (USD Million)
  • Table 49 Global Research Antibodies and Reagents Market Size for Contract Research Organizations, by Country/Region, 2016-2023 (USD Million)
  • Table 50 North America: Research Antibodies and Reagents Market Size, by Country, 2016-2023 (USD Million)
  • Table 51 North America: Market Size, by Product, 2016-2023 (USD Million)
  • Table 52 North America: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 53 North America: Research Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 54 North America: Research Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 55 North America: Research Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 56 North America: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 57 North America: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 58 North America: Market Size, by Application, 2016-2023 (USD Million)
  • Table 59 North America: Market Size, by End User, 2016-2023 (USD Million)
  • Table 60 U.S.: Antibodies and Reagents Market Size, by Product, 2016-2023 (USD Million)
  • Table 61 U.S.: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 62 U.S.: Research Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 63 U.S.: Research Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 64 U.S.: Research Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 65 U.S.: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 66 U.S.: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 67 U.S.: Market Size, by Application, 2016-2023 (USD Million)
  • Table 68 U.S.: Market Size, by End User, 2016-2023 (USD Million)
  • Table 69 Canada: Research Antibodies and Reagents Market Size, by Product, 2016-2023 (USD Million)
  • Table 70 Canada: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 71 Canada: Research Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 72 Canada: Research Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 73 Canada: Research Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 74 Canada: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 75 Canada: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 76 Canada: Market Size, by Application, 2016-2023 (USD Million)
  • Table 77 Canada:Market Size, by End User, 2016-2023 (USD Million)
  • Table 78 Europe: Research Antibodies and Reagents Market Size, by Country, 2016-2023 (USD Million)
  • Table 79 Europe: Market Size, by Product, 2016-2023 (USD Million)
  • Table 80 Europe: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 81 Europe: Research Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 82 Europe: Research Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 83 Europe: Research Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 84 Europe: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 85 Europe: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 86 Europe: Market Size, by Application, 2016-2023 (USD Million)
  • Table 87 Europe: Market Size, by End User, 2016-2023 (USD Million)
  • Table 88 Germany: Research Antibodies and Reagents Market Size, by Product, 2016-2023 (USD Million)
  • Table 89 Germany: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 90 Germany: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 91 Germany: Research Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 92 Germany: Research Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 93 Germany: Research Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 94 Germany: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 95 Germany: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 96 Germany: Market Size, by Application, 2016-2023 (USD Million)
  • Table 97 Germany: Market Size, by End User, 2016-2023 (USD Million)
  • Table 98 France: Research Antibodies and Reagents Market Size, by Product, 2016-2023 (USD Million)
  • Table 99 France: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 100 France: Research Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 101 France: Research Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 102 France: Research Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 103 France: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 104 France: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 105 France: Market Size, by Application, 2016-2023 (USD Million)
  • Table 106 France: Market Size, by End User, 2016-2023 (USD Million)
  • Table 107 U.K.: Research Antibodies and Reagents Market Size, by Product, 2016-2023 (USD Million)
  • Table 108 U.K.: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 109 U.K.: Research Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 110 U.K.: Research Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 111 U.K.: Research Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 112 U.K.: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 113 U.K.: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 114 U.K.: Market Size, by Application, 2016-2023 (USD Million)
  • Table 115 U.K.: Market Size, by End User, 2016-2023 (USD Million)
  • Table 116 Italy: Research Antibodies and Reagents Market Size, by Product, 2016-2023 (USD Million)
  • Table 117 Italy: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 118 Italy: Research Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 119 Italy: Research Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 120 Italy: Research Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 121 Italy: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 122 Italy: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 123 Italy: Market Size, by Application, 2016-2023 (USD Million)
  • Table 124 Italy: Market Size, by End User, 2016-2023 (USD Million)
  • Table 125 Spain: Research Antibodies and Reagents Market Size, by Product, 2016-2023 (USD Million)
  • Table 126 Spain: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 127 Spain: Research Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 128 Spain: Research Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 129 Spain: Research Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 130 Spain: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 131 Spain: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 132 Spain: Market Size, by Application, 2016-2023 (USD Million)
  • Table 133 Spain: Market Size, by End User, 2016-2023 (USD Million)
  • Table 134 RoE: Research Antibodies and Reagents Market Size, by Product, 2016-2023 (USD Million)
  • Table 135 RoE: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 136 RoE: Research Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 137 RoE: Research Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 138 RoE: Research Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 139 RoE: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 140 RoE: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 141 RoE: Market Size, by Application, 2016-2023 (USD Million)
  • Table 142 RoE: Market Size, by End User, 2016-2023 (USD Million)
  • Table 143 Asia Pacific: Research Antibodies and Reagents Market Size, by Product, 2016-2023 (USD Million)
  • Table 144 Asia Pacific: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 145 Asia Pacific: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 146 Asia Pacific: Research Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 147 Asia Pacific: Research Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 148 Asia Pacific: Research Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 149 Asia Pacific: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 150 Asia Pacific: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 151 Asia Pacific: Market Size, by Application, 2016-2023 (USD Million)
  • Table 152 Asia Pacific: Market Size, by End User, 2016-2023 (USD Million)
  • Table 153 China: Research Antibodies and Reagents Market Size, by Product, 2016-2023 (USD Million)
  • Table 154 China: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 155 China: Research Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 156 China: Research Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 157 China: Research Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 158 China: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 159 China: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 160 China: Market Size, by Application, 2016-2023 (USD Million)
  • Table 161 China:Market Size, by End User, 2016-2023 (USD Million)
  • Table 162 Japan: Research Antibodies and Reagents Market Size, by Product, 2016-2023 (USD Million)
  • Table 163 Japan: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 164 Japan: Research Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 165 Japan: Research Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 166 Japan: Research Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 167 Japan: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 168 Japan: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 169 Japan: Market Size, by Application, 2016-2023 (USD Million)
  • Table 170 Japan: Market Size, by End User, 2016-2023 (USD Million)
  • Table 171 India: Research Antibodies and Reagents Market Size, by Product, 2016-2023 (USD Million)
  • Table 172 India: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 173 India: Research Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 174 India: Research Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 175 India: Research Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 176 India: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 177 India: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 178 India: Market Size, by Application, 2016-2023 (USD Million)
  • Table 179 India: Market Size, by End User, 2016-2023 (USD Million)
  • Table 180 RoAPAC: Research Antibodies and Reagents Market Size, by Product, 2016-2023 (USD Million)
  • Table 181 RoAPAC: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 182 RoAPAC: Research Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 183 RoAPAC: Research Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 184 RoAPAC: Research Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 185 RoAPAC: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 186 RoAPAC: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 187 RoAPAC: Market Size, by Application, 2016-2023 (USD Million)
  • Table 188 RoAPAC: Market Size, by End User, 2016-2023 (USD Million)
  • Table 189 RoW: Research Antibodies and Reagents Market Size, by Country, 2016-2023 (USD Million)
  • Table 190 RoW: Market Size, by Product, 2016-2023 (USD Million)
  • Table 191 RoW: Research Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 192 RoW: Research Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 193 RoW: Research Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 194 RoW: Research Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 195 RoW: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 196 RoW: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 197 RoW: Market Size, by Application, 2016-2023 (USD Million)
  • Table 198 RoW: Market Size, by End User, 2016-2023 (USD Million)
  • Table 199 Latin America: Research Antibodies and Reagents Market Size, by Product, 2016-2023 (USD Million)
  • Table 200 Latin America: Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 201 Latin America: Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 202 Latin America: Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 203 Latin America: Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 204 Latin America: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 205 Latin America: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 206 Latin America: Market Size, by Application, 2016-2023 (USD Million)
  • Table 207 Latin America: Market Size, by End User, 2016-2023 (USD Million)
  • Table 208 Middle East & Africa: Research Antibodies and Reagents Market Size, by Product, 2016-2023 (USD Million)
  • Table 209 Middle East & Africa: Antibodies Market Size, by Type, 2016-2023 (USD Million)
  • Table 210 Middle East & Africa: Antibodies Market Size, by Production, 2016-2023 (USD Million)
  • Table 211 Middle East & Africa: Antibodies Market Size, by Source, 2016-2023 (USD Million)
  • Table 212 Middle East & Africa: Antibodies Market Size, by Research Area, 2016-2023 (USD Million)
  • Table 213 Middle East & Africa: Reagents Market Size, by Type, 2016-2023 (USD Million)
  • Table 214 Middle East & Africa: Research Antibodies and Reagents Market Size, by Technology, 2016-2023 (USD Million)
  • Table 215 Middle East & Africa: Market Size, by Application, 2016-2023 (USD Million)
  • Table 216 Middle East & Africa: Market Size, by End User, 2016-2023 (USD Million)
  • Table 217 Number of Developments by the Major Players during 2014-2017
  • Table 218 Approvals
  • Table 219 Partnerships, Agreements, and Collaborations
  • Table 220 Mergers & Acquisitions
  • Table 221 New Product Launches
  • Table 222 Expansions

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Executives Interviewed
  • Figure 3 Primary Research Techniques
  • Figure 4 Market Size Estimation
  • Figure 5 Key Opportunities
  • Figure 6 Key Adopters of Research Antibodies and Reagents
  • Figure 7 Reagents to Dominate the Global Research Antibodies and Reagents Market
  • Figure 8 Global Research Antibodies and Reagents Market Overview: 2017-2022
  • Figure 9 Global Research Antibodies and Reagents Market by Geography, 2017
  • Figure 10 Increase in Publication Related to Genomics, Proteomics or Metabolomics (2008-2016)
  • Figure 11 Medical and Health R&D Expenditure in the U.S.: 2015
  • Figure 12 Number of Academic and Corporate Collaborations
  • Figure 13 Public and Private Expenditure on Healthcare in India, 2008-2016
  • Figure 14 Probability of Success of Biologics in Clinical Trials
  • Figure 15 Increase in Number of Personalized Medicines
  • Figure 16 Estimated Age-Adjusted Prevalence of diabetes by Race, Sex, Age (>18 Years) in the U.S., 2013-2015
  • Figure 17 NIH Spending on Stem Cell Research in the U.S., 2013-2016
  • Figure 18 Number of New Cancer Diagnoses in the U.K., 2009-2014
  • Figure 19 Global Healthcare Expenditure, 2009-2014
  • Figure 20 Monoclonal Antibody Approval Rate, 2008-2015
  • Figure 21 Global Research Antibodies and Reagents Market Share Analysis, by Key Players, 2017
  • Figure 22 Global Research Antibodies and Reagents Market Size, by Product, 2018-2023 (USD Million)
  • Figure 23 Number of Cancer Deaths Globally in 2015
  • Figure 24 Percentage of Research in Infectious Diseases
  • Figure 25 Number of Cardiovascular Disease across the World (in Millions)
  • Figure 26 Global Research Antibodies and Reagents Market Size, by Technology, 2018-2023 (USD Million)
  • Figure 27 Global Research Antibodies and Reagents Market Size, by Application, 2018-2023 (USD Million)
  • Figure 28 Global Life Expectancy and Healthy Life Expectancy: 2015
  • Figure 29 New Chemical or Biological Entities Approved by the U.S. FDA: 2012-2015
  • Figure 30 Worldwide Causes of 2.68 Million Deaths during the Neonatal Period Due to Genetic Abnormalities, 2015
  • Figure 31 Global Research Antibodies and Reagents Market Size, by End User, 2018-2023 (USD Million)
  • Figure 32 Global Research Antibodies and Reagents Market Size, by Geography, 2018-2023 (USD Million)
  • Figure 33 Increasing Aging Population in the U.S.: 2014-2060
  • Figure 34 North America: Research Antibodies and Reagents Market Size, by Country, 2018-2023 (USD Million)
  • Figure 35 Number of People with Chronic Diseases in America.: 2005-2015 (Million)
  • Figure 36 PhRMA Member Company R&D Expenditure in the U.S.
  • Figure 37 Biopharmaceutical Venture Capitalist Investment, 2006-2015 (USD Million)
  • Figure 38 Percentage of Population Aging 65 or Above in G7 Countries: 2016
  • Figure 39 Proportion (% of GDP) of Health Spending by G7 Countries: 2015
  • Figure 40 Europe: Research Antibodies and Reagents Market Size, by Country, 2018-2023 (USD Million)
  • Figure 41 German Pharmaceutical Industry Revenue, 2011-2015 (Euro Billion)
  • Figure 42 Pharmaceutical Production Value in Germany, 2010-2014 (In Euro Billion)
  • Figure 43 Healthcare Expenditure of Germany, 2011-2014 (Euro Billion)
  • Figure 44 Number of Biopharmaceutical Drug Approval: 2012-2015
  • Figure 45 Share of Aged Population (65 or Above) in Total France Population, 2008-2015
  • Figure 46 Share of Total Death in Women in France by Chronic Disease Area: 2014
  • Figure 47 Healthcare Spending Per Capita: 2005-2015
  • Figure 48 Proportional Mortality in the U.K., by Disease Category
  • Figure 49 Annual U.K. Public Spending on Health: 2000-2001 to 2015-2016
  • Figure 50 Production in Pharmaceutical Industry in Major Countries of Europe, 2016
  • Figure 51 Number of Biotech Firms in Italy
  • Figure 52 R&D Project Analysis of Biotech Firms, by Type, 2016
  • Figure 53 Pharmaceutical Spending (% of GDP) in Spain, 2010-2015
  • Figure 54 Proportional Mortality Rate in Poland, 2014
  • Figure 55 Drug Spending as a Percentage of Total Healthcare Expenditure, 2012
  • Figure 56 Proportional Mortality Rate in Switzerland, 2014
  • Figure 57 Share of Non-Communicable Diseases in Total Death in China, 2005-2015 (%)
  • Figure 58 Healthcare Expenditure Per Capita in China: 2008-2014
  • Figure 59 Pharmaceutical Sales in China, 2007-2015
  • Figure 60 Pharmaceutical R&D Expenditure in Japan, 2005-2015
  • Figure 61 Number of New Molecular or Biological Entities Approved in Japan, 2002-2016
  • Figure 62 Indian Pharmaceutical Revenue Growth, 2005-2020
  • Figure 63 Contribution of biotechnology sector in India, by Segment, 2014
  • Figure 64 India: Biotech Industry Market Size, 2010-2015 (USD Billion)
  • Figure 65 Clinical Trial Approval in India: 2013-2016
  • Figure 66 Business Expenditure on Pharmaceutical R&D in Australia: 2009-2012
  • Figure 67 Incidence of Melanoma in Situ of Skin in Australia: 2004-2012
  • Figure 68 Pharmaceutical Industry Turnover in Australia, 2003-2004 to 2012-2013 (USD Billion)
  • Figure 69 Prevalence of Specific Chronic Illness in Korea: 2014
  • Figure 70 Row: Research Antibodies and Reagents Market Size, by Country, 2018-2023 (USD Million)
  • Figure 71 Population in Latin America: 2006-2015 (Million)
  • Figure 72 Forecasted Healthcare Market Size Growth: 2015-2020
  • Figure 73 African Pharmaceutical Market Revenue: 2011-2020
  • Figure 74 Growth Strategies Adopted by the Key Players
  • Figure 75 Key Approvals, by the Leading Players, 2014-2017
  • Figure 76 Partnerships, Agreements, and Collaborations by the Leading Players, 2014-2017
  • Figure 77 Mergers & Acquisitions by the Leading Players, 2014-2017
  • Figure 78 New Product Launches by the Leading Players, 2014-2017
  • Figure 79 Expansions by the Leading Players, 2014-2017
  • Figure 80 GE Healthcare: Financial Overview (2014-2016)
  • Figure 81 Merck & Co., Inc.: Financial Overview (2014-2016)
  • Figure 82 Thermo Fisher Scientific, Inc.: Financial Overview (2014-2016)
  • Figure 83 Amgen Inc.: Financial Overview (2014-2016)
  • Figure 84 F. Hoffmann-La Roche Ltd: Financial Overview (2014-2016)
  • Figure 85 Sanofi: Financial Overview (2014-2016)
  • Figure 86 Johnson & Johnson: Financial Overview (2014-2016)
  • Figure 87 Eli Lilly and Company: Financial Overview (2014-2016)
  • Figure 88 Teva Pharmaceuticals Industries Limited: Financial Overview (2014-2016)
  • Figure 89 Abcam PLC: Financial Overview (2015-2017)
  • Figure 90 Agilent Technologies, Inc.: Financial Overview (2014-2016)
  • Figure 91 Danaher Corporation: Financial Overview (2014-2016)
  • Figure 92 Lonza: Financial Overview (2014-2016)
  • Figure 93 PerkinElmer, Inc.: Financial Overview (2014-2016)
  • Figure 94 GenScript Biotech Corporation: Financial Overview (2014-2016)
  • Figure 95 Bio-Techne Corporation: Financial Overview (2015-2017)
  • Figure 96 Bio-Rad Laboratories, Inc.: Financial Overview (2014-2016)
Back to Top